Institutional Ownership
Rocket Pharmaceuticals Inc
CUSIP 77313F114*W EXP 09/02/202RCKTWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
10
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boothbay Fund Management, LLC | 36.9K | $132.1K |
| 2 | Rtw Investments, LP | 350.0K | $7.2K |
| 3 | Sio Capital Management, LLC | 400.0K | $7.0K |
| 4 | Citadel Advisors LLC | 310.0K | $6.5K |
| 5 | Walleye Capital LLC | 284.3K | $5.9K |
| 6 | Silverarc Capital Management, LLC | 104.8K | $2.2K |
| 7 | Lmr Partners LLP | 75.7K | $1.6K |
| 8 | Affinity Asset Advisors, LLC | 75.0K | $1.2K |
| 9 | Ancora Advisors LLC | 6.0K | $124 |
| 10 | Ubs Group AG | 4.0K | $84 |